Vera Therapeutics (VERA) Long-Term Deferred Tax (2023 - 2026)

Vera Therapeutics' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.5 million, changed N/A from the prior year.
• Long-Term Deferred Tax was $2.0 million for Q1 2026 at Vera Therapeutics, down from $2.5 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $2.5 million in Q4 2025 and bottomed at $719000.0 in Q4 2023.
• A 3-year average of $1.7 million and a median of $2.0 million in 2026 frame the typical range for Long-Term Deferred Tax.